Design characteristics of inhaler devices used for pulmonary delivery of medical aerosols

Surgical Tools and Medical Devices, Second Edition

Volumn , Issue , 2016, Pages 573-592

  Khan, Iftikhar ^a   Yousaf, Sakib ^a   Alhnan, Mohamed Albed ^a   Ahmed, Waqar ^b   Elhissi, Abdelbary ^c   Jackson, Mark J ^d  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^c Qatar University ^*  (Qatar)

^d KANSAS STATE UNIVERSITY   (United States)

Author keywords

Asthma; Drug delivery; Inhaler; Nebulizer; Pulmonary

Indexed keywords

AEROSOLS; ATOMIZERS; BIOLOGICAL ORGANS; DISEASES; DRUG DELIVERY; RESPIRATORY THERAPY;

ASTHMA; DESIGN CHARACTERISTICS; INHALER; METERED-DOSE INHALERS; NEBULIZER; PRESSURIZED-METERED DOSE INHALERS; PULMONARY; PULMONARY DRUG DELIVERY;

DRUG DOSAGE;

EID: 84988564417     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-33489-9_19     Document Type: Chapter

References (72)

1. Arzhavitina, A., & Steckel, H. (2010). Surface active drugs significantly alter the drug output rate from medical nebulizers. International Journal of Pharmaceutics, 384, 128-136.
2. Avvaru, B., Patil, M. N., Gogate, P. R., & Pandit, A. B. (2006). Ultrasonic atomization: Effect of liquid phase properties. Ultrasonics, 44, 146-158.
3. Barry, P. W., & O’Callaghan, C. (1999). An in vitro analysis of the output of salbutamol from different nebulizers. European Respiratory Journal, 13, 1164-1169.
4. Beck-Broichsitter, M., Kleimann, P., Schmehl, T., Betz, T., Bakowsky, U., Kissel, T., et al. (2012). Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers. European Journal of Pharmaceutics and Biopharmaceutics, 82, 272-280.
5. Bridges, P. A., & Taylor, K. M. G. (1998). Nebulisers for the generation of liposomal aerosols. International Journal of Pharmaceutics, 173, 117-125.
6. Bridges, P. A. (2000). An investigation of some of the factors influencing the jet nebulisation of liposomes. International Journal of Pharmaceutics, 204, 69-79.
7. Chougule, M. B., Padhi, B. K., Jinturkar, K. A., & Misra, A. (2007). Development of dry powder inhalers. Recent Patents on Drug Delivery & Formulation, 1, 11-21.
8. Clark, A. R. (1995). Medical aerosol inhalers: Past, present, and future. Aerosol Science and Technology, 22, 374-391.
9. Colacone, A., Wolkove, N., Stern, E., Afilalo, M., Rosenthal, T. M., & Kreisman, H. (1990). Continuous nebulization of albuterol (salbutamol) in acute asthma. Chest, 97, 693-697.
10. Dennis, J. H., Stenton, S. C., Beach, J. R., Avery, A. J., Walters, E. H., & Hendrick, D. J. (1990). Jet and ultrasonic nebuliser output: Use of a new method for direct measurement of aerosol output. Thorax, 45, 728-732.
11. Dhand, R. (2002). Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respiratory Care, 47, 1406-1416 (discussion 1416-1418).
12. Dhand, R. (2003). New nebuliser technology—Aerosol generation by using a vibrating mesh or plate with multiple apertures. University of Missouri Hospital and Clinics, for Omeron Healthcare, Inc.
13. Dhand, R. (2008). Aerosol delivery during mechanical ventilation: From basic techniques to new devices journal of aerosol medicine and pulmonary. Drug Delivery, 21, 45-60.
14. Dolovich, M. (1999). New propellant-free technologies under investigation. Journal of Aerosol Medicine, 12(Suppl 1), S9-s17.
15. Dolovich, M., & Dhand, R. (2011). Aerosol drug delivery: Developments in device design and clinical use? Authors’ reply. The Lancet, 378, 1032-1045.
16. Dunbar, C. A., Watkins, A. P., & Miller, J. F. (1997). An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques. Journal of Aerosol Medicine, 10, 351-368.
17. Elhissi, A., & Taylor, K. M. G. (2005). Delivery of liposomes generated from pro liposomes using air-jet, ultrasonic and vibrating-mesh nebulisers. Journal of Drug Delivery Science and Technology, 15, 261-265.
18. Elhissi, A., Hidayat, K., Phoenix, D. A., Mwesigwa, E., Crean, S., Ahmed, W., et al. (2013). Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology. International Journal of Pharmaceutics, 444, 193-199.
19. Elhissi, A. M. A., & Ahmed, W. (2011). Chapter 1: Advances in design and technology of devices manufactured for drug delivery applications. In M. Jackson & J. P. Davim (Eds.), Medical device manufacturing. USA: Nova Publisher.
20. Elhissi, A. M. A., Faizi, M., Naji, W. F., Gill, H. S., & Taylor, K. M. G. (2007). Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures. International Journal of Pharmaceutics, 334, 62-70.
21. Farr, S. J., Kellaway, I. W., & Carman-Meakin, B. (1987). Assessing the potential of aerosol-generated liposomes from pressurised pack formulations. Journal of Controlled Release, 5, 119-127.
22. Flament, M. P., Leterme, P., & Gayot, A. T. (2001). Study of the technological parameters of ultrasonic nebulisation. Drug Development and Industrial Phamacy, 27, 643-649.
23. Ganderton, D. (1999). Targeted delivery of inhaled drugs: Current challenges and future goals. Journal of Aerosol Medicine, 12(Suppl 1), S3-S8.
24. Ghazanfari, T., Elhissi, A. M., Ding, Z., & Taylor, K. M. (2007). The influence of fluid physicochemical properties on vibrating-mesh nebulization. International Journal of Pharmaceutics, 339, 103-111.
25. Goldbach, P., Brochart, H., & Stamm, A. (1993). Spray-drying of liposomes for a pulmonary administration. II. Retention of encapsulated materials. Drug Development and Industrial Pharmacy, 19, 2623-2636.
26. Grossman, J. (1994). The evolution of inhaler technology. Journal of Asthma, 31, 55-64.
27. Hamilton, R. D., & Guz, A. (1991). Jet and ultrasonic nebuliser output: Use of a new method for direct measurement of aerosol output. Thorax, 46, 151-152.
28. Hess, D., MacIntyre, N., & Mishoe, S. (2011). Respiratory care: Principles and practice. Burlington, MA.: Jones & Bartlett Learning.
29. Hess, D., Fisher, D., Williams, P., Pooler, S., & Kacmarek, R. M. (1996). Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest, 110, 498-505.
30. Hess, R. D. (2000). Nebulizers: Principles and performance. Respiratory care, 45, 609-622.
31. Hugh, D. C. S. (2003). The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. Advanced Drug Delivery Reviews, 55, 807-828.
32. Juntunen-Backman, K., Kajosaari, M., Laurikainen, K., Malinen, A., Kaila, M., Mustala, L., et al. (2002). Comparison of easyhaler metered-dose, dry powder inhaler and a pressurised metered-dose inhaler plus spacer in the treatment of asthma in children. Clinical Drug Investigation, 22, 827-839.
33. Kendrick, A. H., Smith, E. C., & Wilson, R. S. (1997). Selecting and using nebuliser equipment. Thorax, 52(Suppl 2), S92-S101.
34. Khatri, L., Taylor, K. M., Craig, D. Q., & Palin, K. (2001). An assessment of jet and ultrasonic nebulisers for the delivery of lactate dehydrogenase solutions. International Journal of Pharmaceutics, 227, 121-131.
35. Labiris, N. R., & Dolovich, M. B. (2003). Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. British Journal of Clinical Pharmacology, 56, 600-612.
36. Leung, K. K. M., Bridges, P. A., & Taylor, K. M. G. (1996). The stability of liposomes to ultrasonic nebulisation. International Journal of Pharmaceutics, 145, 95-102.
37. Lin, C.-Y., Meng, H.-C., & Fu, C. (2011). An ultrasonic aerosol therapy nebulizer using electroformed palladium-nickel alloy nozzle plates. Sensors and Actuators A: Physical, 169, 187-193.
38. Máiz Carro, L., & Wagner, S. C. (2011). Beneficios de la terapia nebulizada: conceptos básicos. Archivos de BronconeumologíaSupplement, 47(Supplement 6), 2-7.
39. McCallion, O. N. M., Taylor, K. M. G., Thomas, M., & Taylor, A. J. (1995). Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers. Pharmaceutical Research, 12, 1682-1688.
40. McCallion, O. N. M., Taylor, K. M. G., Bridges, P. A., Thomas, M., & Taylor, A. J. (1996). Jet nebulisers for pulmonary drug delivery. International Journal of Pharmaceutics, 130, 1-11.
41. Najlah, M., Vali, A., Taylor, M., Arafat, BT., Ahmed, W., Phoenix, DA., et al. (2013). A study of the effects of sodium halides on the performance of air-jet and vibrating-mesh nebulizers. International Journal of Pharmaceutics, 456, 520.
42. Newman, S. P. (2005). Principles of metered-dose inhaler design. Respiratory Care, 50, 1177-1190.
43. Newman, S. P., & Clarke, S. W. (1983). Therapeutic aerosols 1-physical and practical considerations. Thorax, 38, 881-886.
44. Newman, S. P., & Gee-Turner, A. (2005). The Omron microair vibrating mesh technology nebuliser, a 21st century approach to inhalation therapy. Journal of Applied Therapeutic Research, 5, 29-33.
45. Niven, R. W., & Brain, J. D. (1994). Some functional aspects of air-jet nebulizers. International Journal of Pharmaceutics, 104, 73-85.
46. Niven, R. W., Speer, M., & Schreier, H. (1991). Nebulization of liposomes. II. The effects of size and modeling of solute release profiles. Pharmaceutical Research, 8, 217-221.
47. O’Callaghan, C., & Barry, P. W. (1997). The science of nebulised drug delivery. Thorax, 52 (Suppl 2), S31-S44.
48. O’Riordan, T. G. (2002). Formulations and nebulizer performance. Respiratory Care, 47, 1305-1312 (discussion 1312-1313).
49. Oliveira, R. F., Teixeira, S., Silva, L. F., Teixeira, J. C., & Antunes, H. (2010). Study of a pressurized metered-dose inhaler spray parameters in fluent. London: World Congress on Engineering.
50. Pedersen, S. (1987). Inhaler use in children with asthma. Danish Medical Bulletin, 34, 234-249.
51. Pedersen, S. (1996). Inhalers and nebulizers: Which to choose and why. Respiratory Medicine, 90, 69-77.
52. Pedersen, S., Frost, L., & Arnfred, T. (1986). Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy, 41, 118-124.
53. Phipps, P. R., & Gonda, I. (1990). Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration. CHEST Journal, 97, 1327-1332.
54. Ramlal, S. K., Visser, F. J., Hop, W. C. J., Dekhuijzen, P. N. R., & Heijdra, Y. F. (2013). The effect of bronchodilators administered via aerochamber or a nebulizer on inspiratory lung function parameters. Respiratory Medicine, 107, 1393-1399.
55. Rau, J. L. (2002). Design principles of liquid nebulization devices currently in use. Respiratory Care, 47, 1257-1275 (discussion 1275-1278).
56. Rubin, B. K., & Fink, J. B. (2005). Optimizing aerosol delivery by pressurized metered-dose inhalers. Respiratory Care, 50, 1191-1200.
57. Schreier, H., & Bouwstra, J. (1994). Liposomes and niosomes as topical drug carriers: Dermal and transdermal drug delivery. Journal of Controlled Release, 30, 1-15.
58. Smye, S., & Jollie, M. (1992). A simple mathematical description of jet nebuliser performance. Journal of Aerosol Science, 01, 221-224.
59. Smyth, H., Hickey, A. J., Brace, G., Barbour, T., Gallion, J., & Grove, J. (2006). Spray pattern analysis for metered dose inhalers I: Orifice size, particle size, and droplet motion correlations. Drug Development and Industrial Pharmacy, 32, 1033-1041.
60. Steckel, H., & Eskandar, F. (2003). Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers. European Journal of Pharmaceutical Sciences, 19, 443-455.
61. Takanami, C., & Goto, Y. (1990). Physical properties of antibiotic aerosols produced by jet and ultrasonic nebulizers. Journal of Aerosol Medicine, 3, 45-52.
62. Taylor, K. M. G., & Hoare, C. (1993). Ultrasonic nebulisation of pentamidine isethionate. International Journal of Pharmaceutics, 98, 45-49.
63. Taylor, K. M. G., & McCallion, O. N. M. (1997). Ultrasonic nebulisers for pulmonary drug delivery. International Journal of Pharmaceutics, 153, 93-104.
64. Taylor, K. M. G., & McCallion, O. N. M. (2002). Ultrasonic nebulizers. In J. Swarbrick & J. C. Boylan (Eds.), Encyclopaedia of pharmaceutical technology (pp. 2840-2847). New York: Marcel Dekker.
65. Taylor, K. M. G., Taylor, G., Kellaway, I. W., & Stevens, J. (1990). The stability of liposomes to nebulisation. International Journal of Pharmaceutics, 58, 57-61.
66. Telko, M. J., & Hickey, A. J. (2005). Dry powder inhaler formulation. Respiratory Care, 50, 1209-1227.
67. Terzano, C. (2001). Pressurized metered dose inhalers and add-on devices. Pulmonary Pharmacology & Therapeutics, 14, 351-366.
68. Vecellio, L., Abdelrahim, M. E., Montharu, J., Galle, J., Diot, P., & Dubus, J.-C. (2011). Disposable versus reusable jet nebulizers for cystic fibrosis treatment with tobramycin. Journal of Cystic Fibrosis, 10, 86-92.
69. Vervaet, C., & Byron, P. R. (1999). Drug-surfactant-propellant interactions in HFA-formulations. International Journal of Pharmaceutics, 186, 13-30.
70. Waldrep, J. C., & Dhand, R. (2008). Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Current Drug Delivery, 5, 114-119.
71. Waldrep, J. C., Keyhani, K., Black, M., & Knight, V. (1994). Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol. Chest, 105, 106-110.
72. Yoshiyama, Y., Seki, K., Mino, K., Yazaki, T., Kanke, M., Arai, M., et al. (2003). Nebulization property and utility of a newly designed mesh nebulizer. Oto-Rhino-Laryngology Tokyo, 46, 41-44.